Low vision perspectives on glaucoma

Clinical and Experimental Optometry

Volumn 81, Issue 6, 1998, Pages 280-289

  Wolffsohn, James S ^a   Cochrane, Anthea L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Glaucoma; Low vision; Rehabilitation; Visual impairment

Indexed keywords

EID: 34248530204     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.1998.tb06748.x     Document Type: Article

References (42)

1. Bailey IL. A profile of the low vision population. Optom Monthly 1978; Feb: 137–145.
2. Sorsby A. The incidence and causes of blindness in England and Wales 1963–1968. PHMS Report No 128. London: HMSO, 1972.
3. Taylor HR, Livingston PM, Stanislavsky YL, McCarty CA. Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project. Amer J Ophthalmol 1997; 123: 328–337.
4. National Advisory Eye Council report, Vision Research Planning Committee, Research Program Analysis, 1975; 1 and 2.
5. Robbins HG. Low vision care for the over 80s. Aust J Optom 1981; 64: 243–251.
6. van Rens GH, Chmielowski RJ, Lemmens WA. Results obtained with low vision aids. A retrospective study. Doc Ophthalmol 1991; 78: 205–210.
7. Blomdahl S., Calissendorff BM, Tengrowth B., Wallin O. Blindness in glaucoma patients. Acta Ophthalmol (Copenh) 1997; 75: 589–591.
8. Kanski JJ. Clinical Ophthalmology: a Systematic Approach. 2nd ed. London: Butterworth Heinemann, 1992: Ch 7.
9. Flanagan JG. Glaucoma update: epidemiology and new approaches to medical management. Ophthal Physiol Opt 1998; 18: 126–132.
10. Quigley HA. Number of people with glaucoma worldwide. Brit J Ophthalmol 1996; 80: 389–393.
11. Bengtsson B. The prevalence of glaucoma. Brit J Ophthalmol 1981; 65: 46–49.
12. Leske MC, Connell AM, Wu SY, Hyman L., Schachat AP. Distribution of intraocular pressure. The Barbados Eye Study. Arch Ophthalmol 1997; 115: 1051–1057.
13. Pederson JE, Anderson DR. The mode of progressive optic disc cupping in ocular hypertension and glaucoma. Arch Ophthalmol 1980; 98: 490–495.
14. Flammer J., Drance SM, Zulaf M. Differential light threshold short and long-term fluctuations in patients with glaucoma, normal controls and patients with suspected glaucoma. Arch Ophthalmol 1984; 102: 704–706.
15. Kono Y., Yamamoto T., Kitazawa Y. A new scoring system for comparing the results of high-pass resolution perimetry and differential light sensitivity perimetry in glaucoma patients. Acta Ophthalmol (Copenh) 1997; 75: 537–540.
16. Hart WM, Silverman SE, Trick GL, Nesher R., Gordon MO. Glaucomatous visual field damage. Luminance and color-contrast sensitivities. Invest Ophthalmol Vis Sci 1990; 31: 359–367.
17. Horn FK, Jonas JB, Korth M., Junemann A., Grundler A. The full-field flicker test in early diagnosis of chronic open-angle glaucoma. Amer J Ophthalmol 1997; 123: 313–319.
18. Glynn RJ, Seddon JM, Krug JH Jr, Sahagian CR, Chiavelli ME, Campion EW. Falls in elderly patients with glaucoma. Arch Ophthalmol 1991; 109: 205–210.
19. Nuzzi R., Bellan A., Boles-Carenini B. Glaucoma, lighting and colour vision. An investigation into their interrelationship. Ophthalmologica 1997; 211: 25–31.
20. Drance SM, Schulzer M., Douglas GR, Wijsman K. Short-term effect of intraocular pressure variation on differential light threshold and colour vision. Can J Ophthalmol 1987; 22: 221–225.
21. Poinoosawmy D., Nagasubramanian S., Gloster J. Colour vision in patients with chronic simple glaucoma and ocular hypertension. Brit J Ophthalmol 1980; 64: 852–857.
22. Wilson R., Walker A., Ducker DK, Pitts-Crick R. Risk factors for the rate of progression of glaucomatous visual field loss. Arch Ophthalmol 1982; 100: 737–741.
23. Mickelberg FS, Drance SM. The mode of progression of visual field defects in glaucoma. Amer J Ophthalmol 1984; 98: 443–445.
24. Hart WM, Becker B. The onset and evolution of glaucomatous visual field defects. Ophthalmology 1982; 89: 268–279.
25. Mickelberg FS, Schultzer M., Lau W. The rate of progression of scotomas in glaucoma. Amer J Ophthalmol 1986; 101: 1–6.
26. Berggren L., Widengard I. Visual impairment of open angle glaucoma at first presentation and after a five to 10 year follow-up. J Med Sci 1992; 97: 251–260.
27. Netland PA, Chaturvedi N., Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Amer J Ophthalmol 1993; 115: 608–613.
28. Rulo AH, Greve EL, Hoyng PF. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. Ophthalmology 1997; 104: 1503–1507.
29. Osbourne NN, Cazevieille C., Carvalho AL, DeSantis L. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res 1997; 751: 113–123.
30. Motolko MA, Phelps CD. Contrast sensitivity in asymmetric glaucoma. Int Ophthalmol 1984; 7: 45–59.
31. Nilsson UL. Visual rehabilitation of patients with advanced stages of glaucoma, optic atrophy, myopia or retinitis pigmentosa. Doc Ophthalmol 1988; 70: 363–383.
32. Krefman RA. Reversed telescopes on visual efficiency scores in field-restricted patients. Amer J Optom Physiol Opt 1981; 58: 159–162.
33. Abe H., Hasegawa S., Iwata K. Contrast sensitivity and pattern visual evoked potential in patients with glaucoma. Doc Ophthalmol 1987; 65: 65–70.
34. Bassi CJ, Galanis JC. Binocular visual impairment in glaucoma. Ophthalmology 1991; 98: 1406–1411.
35. Greeves AL, Cole BL, Jacobs RJ. Reliability and validity of simple photographic plate tests of contrast sensitivity. Amer J Optom Physiol Opt 1987; 64: 832–841.
36. Hoeft WW, Hughes MK. A comparative study of low-vision patients: their ocular disease and preference for one specific series of light transmission filter. Amer J Optom Physiol Opt 1981; 58: 841–845.
37. Maino JH, McMahon TT. NoIRs and low vision. J Amer Optom Assoc 1986; 57: 532–535.
38. Davis C., Lovie-Kitchen J., Thompson B. Psychosocial adjustment to age-related macular degeneration. J Vis Imp Blindness 1995; Jan-Feb: 16–27.
39. Parish RK. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Trans Amer Ophthalmol Soc 1996; 19: 919–1026.
40. Gutierrez P., Wilson R., Johnson C., Gordon M., Cioffi GA, Ritch R., Sherwood M., Meng K., Mangione CM. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997; 115: 777–784.
41. Sherwood MB, Garcia-Siekavizza A., Meltzer MI, Hebert A., Burns AF, McGorray S. Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology 1998; 105: 561–566.
42. Wandell PE, Lundstrom M., Brorsson, B. Aberg H. Quality of life among patients with glaucoma in Sweden. Acta Ophthalmol 1997; 75: 584–588.